E098 Effectiveness of ixekizumab at 12 weeks in b/tsDMARD treatment-naive and experienced patients with psoriatic arthritis: PRO-SPIRIT study data

Nicola Gullick; Jacques Morel; Ennio Lubrano; Andris Kronbergs; Marcus Ngantcha; Walid Fakhouri; Domenico Birra; Angels Martinez-Ferrer; Dennis McGonagle; Lars Erik Kristensen; Hasan Tahir

doi:10.1093/rheumatology/keaf142.333

Retour

E098 Effectiveness of ixekizumab at 12 weeks in b/tsDMARD treatment-naive and experienced patients with psoriatic arthritis: PRO-SPIRIT study data

Article de revue

Avec comité de lecture

E098 Effectiveness of ixekizumab at 12 weeks in b/tsDMARD treatment-naive and experienced patients with psoriatic arthritis: PRO-SPIRIT study data

Nicola Gullick, Jacques Morel, Ennio Lubrano, Andris Kronbergs, Marcus Ngantcha, Walid Fakhouri, Domenico Birra, Angels Martinez-Ferrer, Dennis McGonagle, Lars Erik Kristensen, …

Rheumatology (Oxford, England), Vol.64(Supplement_3)

01/04/2025

DOI: https://doi.org/10.1093/rheumatology/keaf142.333

Indicateurs

1 Consultations de la notice

Détails

Titre: E098 Effectiveness of ixekizumab at 12 weeks in b/tsDMARD treatment-naive and experienced patients with psoriatic arthritis: PRO-SPIRIT study data
Créateurs - sans rôle: Nicola Gullick
Jacques Morel
Ennio Lubrano
Andris Kronbergs
Marcus Ngantcha
Walid Fakhouri
Domenico Birra
Angels Martinez-Ferrer
Dennis McGonagle
Lars Erik Kristensen
Hasan Tahir
Détails de publication: Rheumatology (Oxford, England), Vol.64(Supplement_3)
Identifiants: 99148677409311
Unité académique: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Langue: English
Type de ressource: Journal article